Wealthcare Capital Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-300
Closed 274
2020
Q1
$0 Hold
300
﹤0.01% 702
2019
Q4
$0 Hold
300
﹤0.01% 679
2019
Q3
$1K Hold
300
﹤0.01% 188
2019
Q2
$2K Hold
300
﹤0.01% 172
2019
Q1
$2K Hold
300
﹤0.01% 178
2018
Q4
$2K Hold
300
﹤0.01% 175
2018
Q3
$6K Hold
300
﹤0.01% 166
2018
Q2
$17K Hold
300
﹤0.01% 138
2018
Q1
$13K Hold
300
﹤0.01% 135
2017
Q4
$16K Hold
300
﹤0.01% 126
2017
Q3
$13K Hold
300
﹤0.01% 123
2017
Q2
$15K Hold
300
﹤0.01% 116
2017
Q1
$22K Hold
300
﹤0.01% 106
2016
Q4
$17K Hold
300
﹤0.01% 108
2016
Q3
$38K Hold
300
﹤0.01% 84
2016
Q2
$37K Hold
300
﹤0.01% 81
2016
Q1
$25K Hold
300
﹤0.01% 103
2015
Q4
$30K Hold
300
﹤0.01% 102
2015
Q3
$37K Hold
300
﹤0.01% 104
2015
Q2
$46K Buy
+300
New +$49.5K 0.01% 109

Other funds holding ELGX

Wealthcare Capital Management's ELGX Position: Q2 2020 in Review

Wealthcare Capital Management sold out of Endologix Inc (ELGX) in Q2 2020, closing a stake of 300 shares.

Wealthcare Capital Management first reported a position in ELGX in Q2 2015 and held it in 20 quarters. The position peaked at $46K in Q2 2015. 49 funds tracked by Wall St. Rank hold ELGX as of Q2 2020.

  • Wealthcare Capital Management reported no remaining Endologix Inc position as of Q2 2020 after selling out during the quarter.
  • Wealthcare Capital Management sold 300 Endologix Inc shares in Q2 2020.
  • Wealthcare Capital Management first reported a position in Endologix Inc in Q2 2015 and held it in 20 quarters.
  • Wealthcare Capital Management's Endologix Inc position peaked at $46K in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2020.

Based on Wealthcare Capital Management's 13F filing for Q2 2020, filed 29 Jul 2020.